299 related articles for article (PubMed ID: 34247449)
1. Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite-Protein Interaction Network.
Chen D; Zhang Y; Wang W; Chen H; Ling T; Yang R; Wang Y; Duan C; Liu Y; Guo X; Fang L; Liu W; Liu X; Liu J; Otkur W; Qi H; Liu X; Xia T; Liu HX; Piao HL
Adv Sci (Weinh); 2021 Sep; 8(17):e2100311. PubMed ID: 34247449
[TBL] [Abstract][Full Text] [Related]
2. Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model.
Zhang Y; Zeng F; Zeng M; Han X; Cai L; Zhang J; Weng J; Gao Y
Int J Biol Sci; 2021; 17(13):3554-3572. PubMed ID: 34512165
[No Abstract] [Full Text] [Related]
3. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract][Full Text] [Related]
4. Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes.
Bidkhori G; Benfeitas R; Klevstig M; Zhang C; Nielsen J; Uhlen M; Boren J; Mardinoglu A
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11874-E11883. PubMed ID: 30482855
[TBL] [Abstract][Full Text] [Related]
5. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
Gao S; Zhang L; Wang H
Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
[TBL] [Abstract][Full Text] [Related]
6. Bulk and single-cell transcriptome reveal the immuno-prognostic subtypes and tumour microenvironment heterogeneity in HCC.
Ji D; Lu S; Zhang H; Li Z; Wang S; Miao T; Jiang Z; Ao L
Liver Int; 2024 Apr; 44(4):979-995. PubMed ID: 38293784
[TBL] [Abstract][Full Text] [Related]
7. Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis.
Benfeitas R; Bidkhori G; Mukhopadhyay B; Klevstig M; Arif M; Zhang C; Lee S; Cinar R; Nielsen J; Uhlen M; Boren J; Kunos G; Mardinoglu A
EBioMedicine; 2019 Feb; 40():471-487. PubMed ID: 30606699
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma.
Yan J; Gao YM; Deng XL; Wang HS; Shi GT
BMC Cancer; 2023 Nov; 23(1):1161. PubMed ID: 38017425
[TBL] [Abstract][Full Text] [Related]
9. Network-Based Coexpression Analysis Identifies Functional and Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma.
Li J; Zhou J; Kai S; Wang C; Wang D; Jiang J
Biomed Res Int; 2020; 2020():1371632. PubMed ID: 33083449
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis reveals the prognostic value and functions of splicing factors implicated in hepatocellular carcinoma.
Wang Y; Yang F; Shang J; He H; Yang Q
Sci Rep; 2021 Jul; 11(1):15175. PubMed ID: 34312475
[TBL] [Abstract][Full Text] [Related]
11. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
12. An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment.
Wang J; Lou J; Fu L; Jin Q
J Int Med Res; 2021 Feb; 49(2):300060520980646. PubMed ID: 33567957
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the protein-protein interaction network regulating hepatocellular carcinoma metastasis.
Qin G; Dang M; Gao H; Wang H; Luo F; Chen R
Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1114-1122. PubMed ID: 28627476
[TBL] [Abstract][Full Text] [Related]
14. Metabolism-associated molecular classification of hepatocellular carcinoma.
Yang C; Huang X; Liu Z; Qin W; Wang C
Mol Oncol; 2020 Apr; 14(4):896-913. PubMed ID: 31955511
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
16. Development of Prognostic Features of Hepatocellular Carcinoma Based on Metabolic Gene Classification and Immune and Oxidative Stress Characteristic Analysis.
Cui S; Zhang M; Bai S; Bi Y; Cong S; Jin S; Li S; He H; Zhang J
Oxid Med Cell Longev; 2023; 2023():1847700. PubMed ID: 36860731
[TBL] [Abstract][Full Text] [Related]
17. Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma.
Deng Z; Wang J; Xu B; Jin Z; Wu G; Zeng J; Peng M; Guo Y; Wen Z
Biomed Res Int; 2019; 2019():2408348. PubMed ID: 31828095
[TBL] [Abstract][Full Text] [Related]
18. Dysfunctional activation of neurotensin/IL-8 pathway in hepatocellular carcinoma is associated with increased inflammatory response in microenvironment, more epithelial mesenchymal transition in cancer and worse prognosis in patients.
Yu J; Ren X; Chen Y; Liu P; Wei X; Li H; Ying G; Chen K; Winkler H; Hao X
PLoS One; 2013; 8(2):e56069. PubMed ID: 23418512
[TBL] [Abstract][Full Text] [Related]
19. Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
Hong T; Su W; Pan Y; Tian C; Lei G
Front Immunol; 2022; 13():951459. PubMed ID: 36189258
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis.
Lee S; Mardinoglu A; Zhang C; Lee D; Nielsen J
Nucleic Acids Res; 2016 Jul; 44(12):5529-39. PubMed ID: 27216817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
